Lophius Biosciences GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Lophius Biosciences GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10389
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lophius Biosciences GmbH (Lophius) is a biotechnology company that develops and markets T cell-based diagnostic systems and research tools in the areas of transplantation, infectious and autoimmune diseases. The company’s T-track immunoscan assay is a test in natural or induced immune modulation to evaluate the functionality of cell mediated immunity. Its T-track CMV is a diagnostic test to measure CMV-specific cell mediated immunity. Lophius provides T cell tools such as ELISpot kits, T cell stimulants, and custom ELISpot kit. The company offers services including antigen selection, optimization, immune assay development and therapy monitoring. It markets its products through its specialized marketing and distribution partners in Germany, Spain, the Netherlands, Belgium, Luxemburg and Korea. Lophius is headquartered in Regensburg, Germany.

Lophius Biosciences GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lophius Biosciences GmbH, Medical Equipment, Deal Details 10
Venture Financing 10
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 10
Lophius Biosciences Raises USD4.66 Million in Venture Financing 11
Lophius Biosciences Raises Funds through Venture Financing 12
Lophius Biosciences Raises US$2.8 Million In Venture Financing 13
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 14
Partnerships 15
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For Urea Technology 15
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For T-Spot Technology 16
Lophius Biosciences Enters into Agreement with BL&H 17
Lophius Biosciences GmbH – Key Competitors 18
Lophius Biosciences GmbH – Key Employees 19
Lophius Biosciences GmbH – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Mar 22, 2017: Lophius Biosciences Appoints Robert J. Silverman as Supervisory Board Member 21
Other Significant Developments 22
May 31, 2017: Lophius Biosciences Receives Public Grant for the Development of an Advanced Diagnostic Tuberculosis Test 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Lophius Biosciences GmbH, Medical Equipment, Key Facts 2
Lophius Biosciences GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Deals By Market, 2012 to YTD 2018 8
Lophius Biosciences GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Lophius Biosciences Raises USD2.4 Million in First Tranche of Venture Financing 10
Lophius Biosciences Raises USD4.66 Million in Venture Financing 11
Lophius Biosciences Raises Funds through Venture Financing 12
Lophius Biosciences Raises US$2.8 Million In Venture Financing 13
Lophius Biosciences Raises USD5.3 Million in Series C Financing Round 14
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For Urea Technology 15
Oxford Immunotec Enters Into Licensing Agreement With Lophius Biosciences For T-Spot Technology 16
Lophius Biosciences Enters into Agreement with BL&H 17
Lophius Biosciences GmbH, Key Competitors 18
Lophius Biosciences GmbH, Key Employees 19

List of Figures
Lophius Biosciences GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Lophius Biosciences GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Lophius Biosciences GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Lophius Biosciences GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Lophius Biosciences GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Lophius Biosciences GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Vital Therapies Inc (VTL)-製薬・医療分野:企業M&A・提携分析
    Summary Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute l …
  • STR Holdings Inc:企業の戦略的SWOT分析
    STR Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Medidata Solutions Inc (MDSO):企業の財務・戦略的SWOT分析
    Medidata Solutions Inc (MDSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Appili Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Appili Therapeutics Inc (Appili Therapeutics) is a bio-pharmaceutical company developing and commercializing anti-infective drugs for the treatment of infectious diseases and drug-resistant pathogens. Its pipeline products include ATI-1501, an oral suspension antibiotic liquid reformulation …
  • MLM Biologics Inc:企業の製品パイプライン分析2018
    Summary MLM Biologics Inc (MLM Biologics) is a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full thicknes …
  • Enzo Biochem Inc (ENZ):企業の製品パイプライン分析
    Summary Enzo Biochem Inc (Enzo Biochem) is a life sciences and biotechnology company with a focus on harnessing genetic processes for the development of research tools, therapeutics and diagnostics. It also provides reference laboratory services to the medical community. The company focuses on the d …
  • LSK BioPartners Inc-製薬・医療分野:企業M&A・提携分析
    Summary LSK BioPartners Inc (LSK BioPartners) dba LSK BioPharma is a biopharmaceutical company which develops therapies for unmet medical needs in cancer. The company is developing proprietary drug candidate apatinib, a selective VEGFR-2 inhibitor for the treatment of solid tumor cancers such as met …
  • GE Lighting LLC-エネルギー分野:企業M&A・提携分析
    Summary GE Lighting, LLC (GE Lighting), a subsidiary of General Electric Company, is a consumer appliance company that manufactures, sources, and sells energy-efficient solutions. It develops lighting solutions through light-emitting diode (LED), fluorescent, halogen, and high-intensity discharge (H …
  • Harland Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Harland Medical Systems Inc (Harland Medical) is a medical equipment provider that offers medical device coatings. The company offers test equipment, coating systems, laser equipment and dispensing equipment. Its products comprise lubricent UV hydrophilic coatings, bacticent antimicrobial co …
  • Birdstep Technology ASA:企業のM&A・事業提携・投資動向
    Birdstep Technology ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Birdstep Technology ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Tata Motors Ltd (TATAMOTORS):企業の財務・戦略的SWOT分析
    Tata Motors Ltd (TATAMOTORS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Centers for Disease Control and Prevention-製薬・医療分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • Kepler Weber SA (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber SA (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Singularlogic Information Systems And Software Technology S.A.:企業の戦略的SWOT分析
    Singularlogic Information Systems And Software Technology S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees …
  • Sanford Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center provides medical services in the areas of allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding d …
  • Exicure Inc (XCUR):製薬・医療:M&Aディール及び事業提携情報
    Summary Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC is a biotechnology company that discovers, develops, and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid constructs. The company’s technology portfolio includes SNA gene regulati …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Cimarex Energy Co (XEC):企業の財務・戦略的SWOT分析
    Cimarex Energy Co (XEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • DXI Energy Inc (DXI):石油・ガス:M&Aディール及び事業提携情報
    Summary DXI Energy Inc (DXI Energy), formerly Dejour Energy Inc is an upstream oil and gas company. The company undertakes the business of oil and gas exploration, distribution and production. It explores for oil and gas properties in regions of Colorado and British Columbia. DXI Energy operates pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆